These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 20046070)

  • 41. In vitro and in vivo investigation of taste-masking effectiveness of Eudragit E PO as drug particle coating agent in orally disintegrating tablets.
    Drašković M; Medarević D; Aleksić I; Parojčić J
    Drug Dev Ind Pharm; 2017 May; 43(5):723-731. PubMed ID: 27494420
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development of a Novel Co-processed Excipitient Comprising of Xylitol, Mannitol, Microcrystalline Cellulose, and Crospovidone for the Compounding of Memantine Hydrochloride Orally Disintegrating Tablet.
    Hazdi SN; Phang HC; Ng ZQ; Chew YL; Uddin AH; Sarker ZI; Lee SK; Liew KB
    Int J Pharm Compd; 2023; 27(6):522-527. PubMed ID: 38100670
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Formulation and in vitro evaluation of ketoprofen fast-dissolving tablets.
    Comoglu T; Inal O; Yaacoub HB
    Pharm Dev Technol; 2016 Dec; 21(8):901-908. PubMed ID: 25798913
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development and optimization of taste-masked orally disintegrating tablets (ODTs) of clindamycin hydrochloride.
    Cantor SL; Khan MA; Gupta A
    Drug Dev Ind Pharm; 2015; 41(7):1156-64. PubMed ID: 25000481
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Citric Acid Suppresses the Bitter Taste of Olopatadine Hydrochloride Orally Disintegrating Tablets.
    Sotoyama M; Uchida S; Tanaka S; Hakamata A; Odagiri K; Inui N; Watanabe H; Namiki N
    Biol Pharm Bull; 2017; 40(4):451-457. PubMed ID: 28381800
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A new formulation for orally disintegrating tablets using a suspension spray-coating method.
    Okuda Y; Irisawa Y; Okimoto K; Osawa T; Yamashita S
    Int J Pharm; 2009 Dec; 382(1-2):80-7. PubMed ID: 19686825
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preparation and evaluation of orally disintegrating tablets containing taste-masked microcapsules of berberine hydrochloride.
    Hu X; Li Y; Zhang E; Wang X; Xing M; Wang Q; Lei J; Huang H
    AAPS PharmSciTech; 2013 Mar; 14(1):29-37. PubMed ID: 23180226
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development of a novel direct compressible co-processed excipient and its application for formulation of Mirtazapine orally disintegrating tablets.
    Loke YH; Chew YL; Janakiraman AK; Lee SK; Uddin ABMH; Goh CF; Kee PE; Ng HS; Ming LC; Liew KB
    Drug Dev Ind Pharm; 2024 Jan; 50(1):36-44. PubMed ID: 38149637
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of granule properties on rough mouth feel and palatability of orally disintegrating tablets.
    Kimura S; Uchida S; Kanada K; Namiki N
    Int J Pharm; 2015 Apr; 484(1-2):156-62. PubMed ID: 25681720
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of disintegrants on the properties of multiparticulate tablets comprising starch pellets and excipient granules.
    Mehta S; De Beer T; Remon JP; Vervaet C
    Int J Pharm; 2012 Jan; 422(1-2):310-7. PubMed ID: 22101283
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Formulation study for orally disintegrating tablet using partly pregelatinized starch binder.
    Mimura K; Kanada K; Uchida S; Yamada M; Namiki N
    Chem Pharm Bull (Tokyo); 2011; 59(8):959-64. PubMed ID: 21804239
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Application of fluidized hot-melt granulation (FHMG) for the preparation of granules for tableting; properties of granules and tablets prepared by FHMG.
    Kidokoro M; Haramiishi Y; Sagasaki S; Shimizu T; Yamamoto Y
    Drug Dev Ind Pharm; 2002 Jan; 28(1):67-76. PubMed ID: 11858526
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Application of general multilevel factorial design with formulation of fast disintegrating tablets containing croscaremellose sodium and Disintequick MCC-25.
    Solaiman A; Suliman AS; Shinde S; Naz S; Elkordy AA
    Int J Pharm; 2016 Mar; 501(1-2):87-95. PubMed ID: 26827922
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel levocetirizine HCl tablets with enhanced palatability: synergistic effect of combining taste modifiers and effervescence technique.
    Labib GS
    Drug Des Devel Ther; 2015; 9():5135-46. PubMed ID: 26379426
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A new method for evaluating the bitterness of medicines in development using a taste sensor and a disintegration testing apparatus.
    Harada T; Uchida T; Yoshida M; Kobayashi Y; Narazaki R; Ohwaki T
    Chem Pharm Bull (Tokyo); 2010 Aug; 58(8):1009-14. PubMed ID: 20686251
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of preparation method on properties of orally disintegrating tablets made by phase transition.
    Kuno Y; Kojima M; Ando S; Nakagami H
    Int J Pharm; 2008 May; 355(1-2):87-92. PubMed ID: 18182258
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of rapidly disintegrating tablets manufactured by phase transition of sugar alcohols.
    Kuno Y; Kojima M; Ando S; Nakagami H
    J Control Release; 2005 Jun; 105(1-2):16-22. PubMed ID: 15955365
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Taste-masked and affordable donepezil hydrochloride orally disintegrating tablet as promising solution for non-compliance in Alzheimer's disease patients.
    Liew KB; Tan YT; Peh KK
    Drug Dev Ind Pharm; 2015 Apr; 41(4):583-93. PubMed ID: 24495273
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacokinetics of acetaminophen from rapidly disintegrating compressed tablet prepared using microcrystalline cellulose (PH-M-06) and spherical sugar granules.
    Ishikawa T; Koizumi N; Mukai B; Utoguchi N; Fujii M; Matsumoto M; Endo H; Shirotake S; Watanabe Y
    Chem Pharm Bull (Tokyo); 2001 Feb; 49(2):230-2. PubMed ID: 11217114
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Design, Optimization and Evaluation of Orally Disintegrating Tablet of Meloxicam Using Its Menthol Based Solid Dispersions.
    Dehghani H; Taheri A; Homayouni A
    Curr Drug Deliv; 2017; 14(5):709-717. PubMed ID: 27142108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.